dipyridamole has been researched along with Pseudoxanthoma Elasticum in 1 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Pseudoxanthoma Elasticum: An inherited disorder of connective tissue with extensive degeneration and calcification of ELASTIC TISSUE primarily in the skin, eye, and vasculature. At least two forms exist, autosomal recessive and autosomal dominant. This disorder is caused by mutations of one of the ATP-BINDING CASSETTE TRANSPORTERS. Patients are predisposed to MYOCARDIAL INFARCTION and GASTROINTESTINAL HEMORRHAGE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sakata, K | 1 |
| Nakamura, T | 1 |
| Tamekiyo, H | 1 |
| Obayashi, K | 1 |
| Ishikawa, J | 1 |
| Nawada, R | 1 |
| Yoshida, H | 1 |
| Shirotani, M | 1 |
1 other study available for dipyridamole and Pseudoxanthoma Elasticum
| Article | Year |
|---|---|
Pseudoxanthoma elasticum with dipyridamole-induced coronary artery spasm: a case report.
Topics: Coronary Angiography; Coronary Disease; Dipyridamole; Female; Humans; Microvascular Angina; Middle A | 1999 |